Public Relations

More on the Suddenly Disposable (But Still Present) Penn

When labor leaders complained about Burson-Marsteller's union-busting work, Burson CEO Mark Penn remained as chief strategist for Senator Hillar

Hillary Stands By Her Man, But Colombia Dumps Mark Penn

Mark Penn runs the labor-busting PR giant Burson-Marsteller and is the top strategist and pollster for Hillary Clinton's campaign for president. His mixed loyalties have been a continuing image problem for Clinton, to the degree his conflicts makes the news.

The Wall Street Journal first reported, on April 4, that Penn had "met with Colombia's ambassador to the U.S. on Monday to discuss a bilateral free-trade agreement, a pact the presidential candidate (Clinton) opposes." Burson-Marsteller "has a contract with the South American nation to promote congressional approval of the trade deal."

The New York Times later noted that Penn apologized for his conflict of loyalty saying "the meeting was an error in judgment." But that was not enough. Saturday, April 5, Colombia fired Penn (and B-M his company) for his embarrassing bumbling. Still, Hillary Clinton is sticking by her man Mark - for now.

Indian Point on the Potomac: Entergy's New Safety Panel and PR Firm

There's no question that New York's Indian Point nuclear power plant could use some public relations help. But Entergy, Indian Point's owner, might have chosen their new PR firm a little more carefully.

Last year, the state of New York asked the U.S. Nuclear Regulatory Commission (NRC) to deny the plant's license extension application, citing "a long and troubling history of problems." It was "the first time that a state had stepped forward to flatly oppose license renewals," according to the New York Times.

Then, in January, the NRC proposed a $650,000 fine against Indian Point, for having repeatedly missed deadlines to install a new emergency siren system. The fine is "10 times the normal size" of such sanctions, reported the Times.

To address such criticisms, Entergy has retained the Burson-Marsteller firm, funded the pro-nuclear "New York Affordable Reliable Electricity Alliance" and brought Greenpeace activist-turned-PR consultant Patrick Moore to New York. Last month, Entergy made another effort to, in their own words, "provide public assurances about the operation and protection of New York's largest nuclear power facility." They announced the formation of an "Independent Safety Evaluation" panel to investigate Indian Point.

Medialink's 'Fake News' Financial Woes

The giant of the fake news business, Medialink Worldwide, has fallen out of favor with investors. In the last year the company's share price has plummeted from $5.81 to its current level around the $1.70 mark. In its latest annual report, the company glumly states that sales in 2007 in the U.S.

BP Greenwashes Tar Sands Exploitation

The oil giant BP has spent hundreds of millions of dollars on PR, greenwashing its image to be perceived as better than Exxon, Shell and others. But "a recent change in corporate policy threatens that green-friendly image," reports Michael Moreci.

Imaging Study Leaves Tobacco Funding Out of the Picture

The lead author of the largest lung cancer screening study ever performed has come under fire for accepting cigarette company funding for the study. Dr.

Lobbying Wine in a PR Bottle?

According to the Tennessee Ethics Commission's staff, a public relations firm that set up a front group that's encouraging people to contact legislators needs to register as a lobbyist. At issue is a proposal to allow Tennesseans to order wine over the Internet. The Tennessee Wine and Spirits Wholesalers, which opposes the bill, hired the prominent Nashville firm Seigenthaler Public Relations.

Telling It Like It Is

The director of external relations for Procter & Gamble, Mark Chakravarty, recently told a UK healthcare PR conference that the drug industry is less than popular with the public. "There is a high suspicion of the pharma industry. Greed, dishonesty and fraud are some of its associations. The clinical trial press this week and an increased number of drug scandals add to this image," he said.

Syndicate content